Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

The maximum dosage of methotrexate (MTX) for treatment of rheumatoid arthritis (RA) formally approved in Japan is 8 mg/week. We intended to examine the efficacy and safety of MTX at dosages over 8 mg/week in Japanese rheumatoid arthritis patients using the large Institute of Rheumatology, Rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Seto, Yohei, Tanaka, Eiichi, Inoue, Eisuke, Nakajima, Ayako, Taniguchi, Atsuo, Momohara, Shigeki, Yamanaka, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236829/
https://www.ncbi.nlm.nih.gov/pubmed/21424533
http://dx.doi.org/10.1007/s10165-011-0445-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236829/
https://www.ncbi.nlm.nih.gov/pubmed/21424533
http://dx.doi.org/10.1007/s10165-011-0445-4

Ejemplares similares